Healwell AI (TSE:AID – Get Free Report) was upgraded by analysts at Canaccord Genuity Group to a “moderate buy” rating in a report released on Tuesday,Zacks.com reports.
Separately, TD Securities raised Healwell AI to a “strong-buy” rating in a report on Thursday, April 2nd. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company’s stock. Based on data from MarketBeat, Healwell AI presently has an average rating of “Strong Buy”.
Get Our Latest Stock Analysis on Healwell AI
Healwell AI Price Performance
Further Reading
- Five stocks we like better than Healwell AI
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Healwell AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healwell AI and related companies with MarketBeat.com's FREE daily email newsletter.
